#United Kingdom #Drug Development #IDBS #Woking #GxP Compliance

IDBS Celebrates Innovations and Customer Achievements in 2025

As we approach the end of 2025, IDBS takes a moment to celebrate notable successes of its clients and the key innovations that have propelled scientific digital transformation this year. From launching IDBS Polar Control to enhancing tech transfer capabilities, these advancements aim to streamline processes, reduce return on investment time, and enable smarter decision-making in drug development and bioprocessing.

Advancements in Process Lifecycle Management

The year kicked off with the introduction of Polar Control, a cutting-edge feature within the IDBS Polar platform—a GxP-compliant enterprise lab informatics software. This new capability acts as a comprehensive 'recipe book' for drug development, specifically designed to improve parameter and process lifecycle management. By addressing inefficiencies in developing process knowledge, Polar Control facilitates a smoother tech transfer process, which is crucial for expediting development timelines.

Turning Data into Actionable Insights

In an innovative push, IDBS unveiled a cloud-native integration framework for the Polar platform, significantly streamlining the management of large datasets. This enhanced system allows for broader data-type support and easier configuration. A notable use case was demonstrated at the recent i3 user group meeting, showcasing a seamless connection to Cytiva's UNICORN software for effective downstream purification workflows—transforming raw chromatography data into valuable insights for researchers.

Innovative Workflow Accelerators

Expanding its library of workflow accelerators, IDBS launched several new applications designed to accelerate operations and ensure compliance across drug development processes. These tools deliver high-quality data quickly, enhancing decision-making. For instance, the BioA Study Report Insight App enables real-time monitoring of bioanalysis operations, while the DMPK Insight App streamlines drug metabolism studies by automating calculations and standardizing procedures.

Next-Level AI Integration

In 2025, IDBS made significant investments in artificial intelligence capabilities, empowering scientists to tackle routine tasks more efficiently—like summarizing research papers and conducting semantic searches. This year also saw the integration of Agentic AI with the goal of optimizing the